Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

June 1, 2025

Conditions
Celiac DiseaseFood Intolerance
Interventions
DIETARY_SUPPLEMENT

Wheat gluten 1000 mg

Nothing to add here

DIETARY_SUPPLEMENT

Barley gluten 1000 mg

Nothing to add here

DIETARY_SUPPLEMENT

Barley gluten 50 mg

Nothing to add here

DIETARY_SUPPLEMENT

Barley hydrolyzed gluten 50 mg

Nothing to add here

DIETARY_SUPPLEMENT

Placebo slurry

In slurry, measurement of immune activation (Interleukin-2) four hours after intake

Trial Locations (2)

55131

Clinical Center for Celiac Disease and Autoimmunity, Mainz

0881

Dept of Gastroenterology, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT06151782 - Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients? | Biotech Hunter | Biotech Hunter